lorazepam has been researched along with Basal Ganglia Cerebrovascular Disease in 1 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
Basal Ganglia Cerebrovascular Disease: A pathological condition caused by impaired blood flow in the basal regions of cerebral hemispheres (BASAL GANGLIA), such as INFARCTION; HEMORRHAGE; or ISCHEMIA in vessels of this brain region including the lateral lenticulostriate arteries. Primary clinical manifestations include involuntary movements (DYSKINESIAS) and muscle weakness (HEMIPARESIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carmin, CN | 1 |
| Wiegartz, PS | 1 |
| Yunus, U | 1 |
| Gillock, KL | 1 |
1 other study available for lorazepam and Basal Ganglia Cerebrovascular Disease
| Article | Year |
|---|---|
Treatment of late-onset OCD following basal ganglia infarct.
Topics: Aged; Basal Ganglia Cerebrovascular Disease; Cerebral Infarction; Cognitive Behavioral Therapy; Comb | 2002 |